Financials in USD. Standardized financial statements.
A compact view of how DNAPrint Genomics, Inc. turns revenue into operating income and net income.
| Metric | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 |
|---|---|---|---|---|---|---|
| Revenue? | $2.43M | $1.28M | $785,632 | $709,638 | $184,551 | $14,389 |
| Revenue Growth? | +90.7% | +62.4% | +10.7% | +284.5% | +1182.6% | 0.0% |
| Cost of Revenue? | $1.68M | $950,472 | $507,927 | $432,224 | $73,205 | $5,914 |
| Gross Profit? | $754,068 | $325,031 | $277,705 | $277,414 | $111,346 | $8,475 |
| Gross Margin? | +31.0% | +25.5% | +35.3% | +39.1% | +60.3% | +58.9% |
| Operating Expenses? | -$8.11M | -$4.34M | -$3.06M | -$5.96M | -$2.50M | -$2.54M |
| Operating Income? | -$8.87M | -$4.66M | $3.33M | $6.23M | $2.61M | $2.55M |
| EBITDA? | -$8.93M | -$2.38M | -$2.28M | -$5.19M | -$2.16M | -$2.18M |
| Income Before Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$12.35M | -$8.72M | -$3.73M | -$7.79M | -$3.11M | -$2.59M |
| EPS? | $-0.03 | $-0.09 | $-0.20 | $-3.20 | $-0.14 | $-0.20 |
| Diluted EPS? | $-0.03 | $-0.09 | $-0.20 | $-3.20 | $-0.14 | $-0.20 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality